100 related articles for article (PubMed ID: 20853719)
1. [Type 2 diabetes: is the treatment based on evidence?].
Boussageon R
Rev Med Suisse; 2010 Sep; 6(260):1624-5; author reply 1625. PubMed ID: 20853719
[No Abstract] [Full Text] [Related]
2. [PPAR agonists do not come up to expectations. Hope about the preventive effect in type 2 diabetes has come to nought].
Olsson AG
Lakartidningen; 2006 Aug 30-Sep 5; 103(35):2454-5. PubMed ID: 17002160
[No Abstract] [Full Text] [Related]
3. Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: a comment to the debate on randomized controlled trials (For debate).
Richter B; Berger M
Diabetologia; 2000 Apr; 43(4):528-32. PubMed ID: 10819251
[No Abstract] [Full Text] [Related]
4. [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].
Laakso M
Duodecim; 2003; 119(20):1921-3. PubMed ID: 14639996
[No Abstract] [Full Text] [Related]
5. [The effect of glitazones on the progression of type 2 diabetes and on cardiovascular endpoints].
Schatz H
Dtsch Med Wochenschr; 2005 Aug; 130(31-32):1825-30. PubMed ID: 16052448
[No Abstract] [Full Text] [Related]
6. The evidence for insulin lispro.
McCormack J; Bassett K
CMAJ; 1998 Dec; 159(11):1353-5. PubMed ID: 9861200
[No Abstract] [Full Text] [Related]
7. [How does the PROactive Study change therapy of diabetes?].
Erdmann E
MMW Fortschr Med; 2005 Oct; 147(41):6. PubMed ID: 16270501
[No Abstract] [Full Text] [Related]
8. Does intensive glycemic control improve cardiovascular outcomes?
Pendergrass M
Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):529. PubMed ID: 18806805
[No Abstract] [Full Text] [Related]
9. [Clinical advances in diabetes].
Martin S; Scherbaum WA
Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1461-2. PubMed ID: 16794976
[No Abstract] [Full Text] [Related]
10. [Pioglitazone in evaluation by IQWiG (Institute for Quality and Cost Effectiveness in Public Health)--tunnel vision instead of broad view].
MMW Fortschr Med; 2008 Aug; 150(32-35):56-7. PubMed ID: 19009700
[No Abstract] [Full Text] [Related]
11. Effects of hypoglycemic agents on mortality and major cardiovascular outcomes in patients with type 2 diabetes mellitus: a narrative review [88].
Miranda VP; Rodrigues MJ; Gonçalves FR; Nunes JP
Rev Port Cardiol; 2009 Oct; 28(10):1099-119. PubMed ID: 20058777
[TBL] [Abstract][Full Text] [Related]
12. What to make of ACCORD. Surprising new results from the landmark diabetes study.
Johns Hopkins Med Lett Health After 50; 2010 Sep; 22(7):1-2, 7. PubMed ID: 20848750
[No Abstract] [Full Text] [Related]
13. [Evidence-based reduction of complications of type 2 diabetes following intensive antihypertensive treatment].
Hansen KW; Poulsen PL; Mogensen CE
Ugeskr Laeger; 1999 Aug; 161(34):4764. PubMed ID: 10500468
[No Abstract] [Full Text] [Related]
14. Opinion: Tight blood glucose control and cardiovascular disease in the elderly diabetic? Let the randomized controlled trials speak for themselves.
Sherman FT
Geriatrics; 2008 Aug; 63(8):8-10. PubMed ID: 18672951
[No Abstract] [Full Text] [Related]
15. Assessing the cardiovascular safety of diabetes therapies.
Goldfine AB
N Engl J Med; 2008 Sep; 359(11):1092-5. PubMed ID: 18784098
[No Abstract] [Full Text] [Related]
16. [Retrolective study design -- a new tool of evidence-based medicine].
Martin S
Dtsch Med Wochenschr; 2005 Jul; 130 Suppl 2():S86-90. PubMed ID: 15988675
[No Abstract] [Full Text] [Related]
17. Treatment intensification in patients with type 2 diabetes.
Barnett AH
Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():iii. PubMed ID: 18435667
[No Abstract] [Full Text] [Related]
18. [Is an evidence-based therapy of inpatients with type 2 diabetes possible from studies used for formulating therapy guidelines?].
Häuser W; Ziehl S; Poltorak P; Grandt D
Dtsch Med Wochenschr; 2005 Apr; 130(17):1069-73. PubMed ID: 15841421
[TBL] [Abstract][Full Text] [Related]
19. [Evidence-based treatment of hypertension in type 2-diabetes. New studies support active blood pressure reduction].
Nilsson P
Lakartidningen; 2000 Feb; 97(6):568-72. PubMed ID: 10707481
[TBL] [Abstract][Full Text] [Related]
20. Drugs for type 2 diabetes mellitus: the imperative for cardiovascular outcome assessment.
Gore MO; McGuire DK
Diab Vasc Dis Res; 2012 Apr; 9(2):85-8. PubMed ID: 22496441
[No Abstract] [Full Text] [Related]
[Next] [New Search]
